RBC Life Sciences Inc
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products. The company offers wellness products, weight loss, sports, and fitness products. RBC Life Sciences, Inc. is headquartered in Irving, Texas.
RBC Life Sciences Inc (RBCL) - Net Assets
Latest net assets as of September 2017: $6.58 Million USD
Based on the latest financial reports, RBC Life Sciences Inc (RBCL) has net assets worth $6.58 Million USD as of September 2017.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.85 Million) and total liabilities ($5.27 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.58 Million |
| % of Total Assets | 55.51% |
| Annual Growth Rate | 6.6% |
| 5-Year Change | -25.07% |
| 10-Year Change | -5.91% |
| Growth Volatility | 21.53 |
RBC Life Sciences Inc - Net Assets Trend (1996–2016)
This chart illustrates how RBC Life Sciences Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for RBC Life Sciences Inc (1996–2016)
The table below shows the annual net assets of RBC Life Sciences Inc from 1996 to 2016.
| Year | Net Assets | Change |
|---|---|---|
| 2016-12-31 | $7.13 Million | -9.51% |
| 2015-12-31 | $7.88 Million | -6.48% |
| 2014-12-31 | $8.43 Million | -6.53% |
| 2013-12-31 | $9.01 Million | -5.27% |
| 2012-12-31 | $9.52 Million | -3.53% |
| 2011-12-31 | $9.86 Million | -0.12% |
| 2010-12-31 | $9.88 Million | +7.12% |
| 2009-12-31 | $9.22 Million | -1.78% |
| 2008-12-31 | $9.39 Million | +23.87% |
| 2007-12-31 | $7.58 Million | +38.22% |
| 2006-12-31 | $5.48 Million | +11.96% |
| 2005-12-31 | $4.90 Million | +13.41% |
| 2004-12-31 | $4.32 Million | +15.31% |
| 2003-12-31 | $3.74 Million | +17.44% |
| 2002-12-31 | $3.19 Million | -14.79% |
| 2001-12-31 | $3.74 Million | -22.07% |
| 2000-12-31 | $4.80 Million | +8.12% |
| 1999-12-31 | $4.44 Million | +9.35% |
| 1998-12-31 | $4.06 Million | +13.34% |
| 1997-12-31 | $3.58 Million | +80.61% |
| 1996-12-31 | $1.98 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to RBC Life Sciences Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 41799700.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2016)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.21K | 0.03% |
| Other Comprehensive Income | $328.82K | 4.61% |
| Other Components | $13.71 Million | 192.34% |
| Total Equity | $7.13 Million | 100.00% |
RBC Life Sciences Inc Competitors by Market Cap
The table below lists competitors of RBC Life Sciences Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EPIC Corp
PINK:EPOR
|
$0.94 |
|
Novation Hldgs Inc.
PINK:NOHO
|
$0.94 |
|
BioLife Sciences Inc
PINK:BLFE
|
$0.94 |
|
Beard Co
PINK:BRCOQ
|
$0.94 |
|
Liberty International Holding Corp
PINK:PDPG
|
$0.94 |
|
USA Recycling Industries Inc
PINK:USRI
|
$0.94 |
|
Dewmar Intl Bmc Inc
PINK:DEWM
|
$0.94 |
|
Premier Power Renewable Energy Inc
PINK:PPRW
|
$0.94 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RBC Life Sciences Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2015 to 2016, total equity changed from 7,879,672 to 7,130,341, a change of -749,331 (-9.5%).
- Net loss of 756,284 reduced equity.
- Other comprehensive income increased equity by 6,953.
Equity Change Factors (2015 to 2016)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-756.28K | -10.61% |
| Other Comprehensive Income | $6.95K | +0.1% |
| Total Change | $- | -9.51% |
Book Value vs Market Value Analysis
This analysis compares RBC Life Sciences Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-12-31 | $-0.08 | $0.00 | x |
| 1997-12-31 | $2.65 | $0.00 | x |
| 1998-12-31 | $2.93 | $0.00 | x |
| 1999-12-31 | $3.19 | $0.00 | x |
| 2000-12-31 | $3.45 | $0.00 | x |
| 2001-12-31 | $2.58 | $0.00 | x |
| 2002-12-31 | $2.28 | $0.00 | x |
| 2003-12-31 | $1.98 | $0.00 | x |
| 2004-12-31 | $2.06 | $0.00 | x |
| 2005-12-31 | $2.28 | $0.00 | x |
| 2006-12-31 | $2.49 | $0.00 | x |
| 2007-12-31 | $3.41 | $0.00 | x |
| 2008-12-31 | $4.11 | $0.00 | x |
| 2009-12-31 | $4.21 | $0.00 | x |
| 2010-12-31 | $4.40 | $0.00 | x |
| 2011-12-31 | $4.44 | $0.00 | x |
| 2012-12-31 | $4.28 | $0.00 | x |
| 2013-12-31 | $4.06 | $0.00 | x |
| 2014-12-31 | $3.81 | $0.00 | x |
| 2015-12-31 | $3.56 | $0.00 | x |
| 2016-12-31 | $3.22 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently RBC Life Sciences Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.61%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.93%
- • Asset Turnover: 2.35x
- • Equity Multiplier: 1.54x
- Recent ROE (-10.61%) is below the historical average (-0.77%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | 0.00% | -0.29% | 2.18x | 0.00x | $-13.99K |
| 1997 | -19.17% | -4.89% | 2.35x | 1.67x | $-1.05 Million |
| 1998 | -0.83% | -0.12% | 3.46x | 2.02x | $-439.75K |
| 1999 | 7.24% | 0.90% | 3.92x | 2.05x | $-122.44K |
| 2000 | 11.05% | 1.33% | 3.72x | 2.24x | $50.53K |
| 2001 | -31.02% | -3.30% | 2.69x | 3.50x | $-1.47 Million |
| 2002 | -17.45% | -2.29% | 2.18x | 3.48x | $-875.36K |
| 2003 | -2.81% | -0.58% | 1.70x | 2.84x | $-479.80K |
| 2004 | 12.44% | 2.94% | 1.64x | 2.58x | $105.38K |
| 2005 | 12.09% | 3.06% | 1.53x | 2.59x | $102.34K |
| 2006 | 7.96% | 2.01% | 1.61x | 2.47x | $-112.07K |
| 2007 | 22.33% | 6.26% | 1.41x | 2.53x | $934.44K |
| 2008 | 17.21% | 5.31% | 1.54x | 2.11x | $677.07K |
| 2009 | -3.63% | -1.34% | 1.34x | 2.02x | $-1.26 Million |
| 2010 | 5.65% | 1.98% | 1.53x | 1.86x | $-429.81K |
| 2011 | -0.72% | -0.25% | 1.51x | 1.91x | $-1.06 Million |
| 2012 | -3.80% | -1.44% | 1.40x | 1.89x | $-1.31 Million |
| 2013 | -5.55% | -1.96% | 1.45x | 1.95x | $-1.40 Million |
| 2014 | -7.15% | -2.13% | 1.77x | 1.90x | $-1.45 Million |
| 2015 | -9.41% | -3.04% | 2.16x | 1.43x | $-1.53 Million |
| 2016 | -10.61% | -2.93% | 2.35x | 1.54x | $-1.47 Million |
Industry Comparison
This section compares RBC Life Sciences Inc's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,833,853,398
- Average return on equity (ROE) among peers: 27.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| RBC Life Sciences Inc (RBCL) | $6.58 Million | 0.00% | 0.80x | $0.94 |
| Acme United Corporation (ACU) | $19.90 Million | 2.51% | 0.55x | $132.86 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $3.02 Billion | 8.59% | 0.75x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.70 Billion | 16.88% | 0.41x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $12.35 Billion | 8.22% | 0.18x | $1.01 Billion |
| Bemax Inc (BMXC) | $-244.86K | 0.00% | 0.00x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $335.48 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $11.97 Million |
| Church & Dwight Company Inc (CHD) | $284.43 Million | 16.52% | 2.34x | $22.97 Billion |
| Colgate-Palmolive Company (CL) | $971.00 Million | 223.07% | 14.49x | $67.85 Billion |